Nifty edges up 0.23%, Sensex flat in expiry churn

India’s stock market today ended with a split verdict: the Nifty 50 held onto gains, while the Sensex slipped into the red after a sharp swing in the closing auction on weekly expiry.

The Nifty today rose 53 points to finish near 23,271, while the Sensex today ended down 22 points at 74,315. The action looked less like a directional call and more like positioning in index heavyweights, with the final minutes doing most of the damage.

Expiry day, one big twist at the close

The clearest feature of Thursday’s tape was the closing auction volatility. The Sensex briefly spiked during the CAS and then gave it all back, highlighting how expiry flows can overpower intraday signals.

For investors, the takeaway is simple: expiry moves can distort the index print without necessarily changing the underlying risk appetite. If you were tracking breadth and sector rotation through the day, the market tone was steadier than the Sensex close suggests.

Global cues: Fed hikes, yields pause

Overnight and early-global cues stayed dominated by the US Federal Reserve. The Fed delivered a widely expected 25 basis point hike, taking the benchmark rate to 3.75%–4.00%, and signalled further tightening could follow.

That guidance kept global rates in focus. Still, there was some relief from a pause in the global bond selloff, with yields largely flat to lower in early trading. Equity sentiment improved modestly in Europe, where shares edged higher.

Oil cools off, but the ceiling remains high

Crude prices eased for a second session, which helped risk appetite globally. Even so, oil stayed above $100 a barrel, meaning the market is not ready to declare an inflation all-clear.

For India, the oil line matters on two fronts: the inflation trajectory and the rupee’s comfort zone. A softer oil tape can reduce immediate pressure, but elevated absolute levels still feed into macro caution and sector preferences.

How Indian equities traded through the day

Indian benchmarks were choppy, but the broader narrative was rotation rather than panic. The session followed recent volatility, and the market appeared to be balancing three forces:

• global rates staying higher-for-longer after the Fed’s move
• some relief from softer oil and steadier yields
• domestic positioning around expiry

Compared with earlier sessions where global cues dominated risk-off behaviour, Thursday felt more like investors selectively adding and trimming exposure rather than exiting equities wholesale.

Sectors: autos and PSU banks stand out

Autos and PSU banks were key pockets of support, consistent with the live market chatter that these groups attracted buying. In a tape where investors are unsure about the next move in global yields, domestic cyclicals and financials can still see demand, especially when valuations look more reasonable after a pullback.

The flip side was that the rally was not uniform. Expiry-day index churn often masks which pockets truly saw conviction buying versus short-term trading flows.

Company news that mattered

While index moves were modest, a few company-specific developments stood out for fundamentally minded investors.

Yatharth Hospitals announced that Advent International will invest Rs 3,150 crore to acquire a 24.9% minority stake. The transaction is subject to customary closing conditions, and the Tyagi family will remain the largest shareholder. For the sector, it reinforces that scaled hospital platforms with growth visibility continue to attract global private equity capital.

Zee Learn disclosed it received a letter from ACRE invoking a corporate guarantee, calling upon the company to pay Rs 818.23 crore. The company said it is evaluating next steps. The headline number is large enough to keep leverage and contingent liabilities front and centre, and investors will watch how the company addresses the claim and what it means for liquidity.

Bharat Immunological & Biological Corporation said the Government of India has approved the closure or winding-up of the company, citing a communication from the Department of Biotechnology received on Sep 17. This is a major corporate action and changes the lens through which the stock is evaluated, with the process details and timelines becoming key.

What this means for investors

Thursday’s finish underlines a market that is trading tactically around global rates rather than repricing India’s growth story. With the Fed now back in hiking mode and signalling more, the sensitivity to US yields and the dollar is likely to stay elevated.

In that environment, investors typically watch for three things: whether crude keeps easing, whether bond yields remain stable rather than resume a sharp climb, and whether foreign flows stay supportive.

At the portfolio level, expiry-week volatility is a reminder to avoid over-reading single-session index prints. It also favours discipline on entry points, especially in rate-sensitive segments.

Near-term triggers to track

The next few sessions will likely take cues from a tight set of variables:

Bank of England decision and commentary, which global markets are already positioning for.

US data prints, particularly labour market readings such as jobless claims, for any signal that the Fed’s tightening path could accelerate or slow.

Crude oil direction, which remains a swing factor for India’s inflation expectations.

Bond yield behaviour, since a renewed spike can quickly rotate investors out of risk and compress equity valuations.

The setup for the next session

The Nifty’s ability to close higher despite expiry churn is a small positive, but the split close also shows how fragile sentiment can look when the market is dominated by flows rather than fundamentals.

Investors should watch whether leadership broadens beyond the day’s pockets of strength, and whether the next round of global macro headlines pushes India back into defensive mode or allows the market to stabilise around current levels.